Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07142369 · ClinicalTrials.gov registry record · NA
Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines
A NA study, sponsored by Rush University Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT07142369 is a NA study that has not yet begun recruiting, run by Rush University Medical Center. The registered enrollment target is 99 participants.
The verdict
NCT07142369, a NA study, has not yet begun recruiting, sponsored by Rush University Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to determine what effects the withdrawal of excess knee joint fluid or the injection of a factor from the blood has on swelling after a sudden anterior cruciate ligament (ACL) rupture of the knee.
Interventions
- PROCEDURE Synovial Fluid withdrawal at the preoperative clinic visit
- PROCEDURE Platelet-Rich Plasma (PRP) preparation and injection
- PROCEDURE Synovial fluid withdrawal at the time of surgery
- PROCEDURE 3mL synovial fluid withdrawn at the preoperative visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2026-09 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07142369
The ClinicalTrials.gov registry entry for NCT07142369 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Synovial Fluid withdrawal at the preoperative clinic visit is the first listed.
NCT07142369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07142369 about?
NCT07142369 is a clinical study titled "Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines". The purpose of this study is to determine what effects the withdrawal of excess knee joint fluid or the injection of a factor from the blood has on swelling after a sudden anterior cruciate ligament (ACL) rupture of the knee.
What is the current status of trial NCT07142369?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2026-09. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07142369?
The interventions under investigation include: Synovial Fluid withdrawal at the preoperative clinic visit (PROCEDURE), Platelet-Rich Plasma (PRP) preparation and injection (PROCEDURE), Synovial fluid withdrawal at the time of surgery (PROCEDURE), 3mL synovial fluid withdrawn at the preoperative visit (PROCEDURE).
Who is sponsoring clinical trial NCT07142369?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.